Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus
2010 ◽
Vol 120
(8)
◽
pp. 2858-2866
◽
2021 ◽
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
2010 ◽
Vol 39
(3)
◽
pp. 325-330
◽